Before We Start
Metformin — the most prescribed diabetes drug and the one to hold before procedures
Metformin is a biguanide — the first-line oral medication for Type 2 diabetes. It is prescribed to over 120 million people worldwide. In most patients it is safe, effective, and remarkably well-tolerated. But in specific clinical situations, metformin becomes dangerous — and the nurse who knows when to hold it prevents a potentially fatal complication.
The danger is not hyperglycemia or hypoglycemia. The danger is lactic acidosis — a life-threatening buildup of lactic acid in the blood that can occur when metformin accumulates in patients whose kidneys cannot clear it, or who are exposed to contrast dye.
💡 How Metformin Actually Works
Metformin works primarily by suppressing glucose production in the liver (hepatic gluconeogenesis). Between meals, the liver releases stored glucose into the blood — in Type 2 diabetes, this process is overactive, causing fasting hyperglycemia. Metformin tells the liver to dial it back. It also improves insulin sensitivity in muscle cells and slows glucose absorption from the gut. Importantly: metformin does NOT cause hypoglycemia on its own — it only lowers the glucose the liver is producing, not below normal levels.
The Critical Safety Rule
HOLD metformin before contrast dye and surgery — lactic acidosis risk
Contrast Dye — Hold 24–48 Hours Before and After
Contrast nephropathy + metformin accumulation = lactic acidosis
Iodinated contrast dye — used in CT scans, cardiac catheterizations, angiograms, and other imaging procedures — can temporarily impair kidney function (contrast-induced nephropathy). In a patient with normal kidneys, this temporary impairment is usually mild and reversible. But metformin is excreted entirely by the kidneys. If the kidneys stop working well, metformin cannot be cleared — it accumulates in the blood.
How lactic acidosis develops: At high concentrations, metformin interferes with mitochondrial function — the energy-producing machinery of cells. Cells unable to produce energy aerobically switch to anaerobic metabolism, which produces lactic acid as a byproduct. Lactic acid accumulates, blood pH drops, and lactic acidosis develops.
The clinical standard:
• Hold metformin 24–48 hours BEFORE the procedure (if possible)
• Do not restart until kidney function is confirmed normal — typically 48 hours after the procedure
• Check creatinine and GFR before restarting
• If emergency contrast is needed and metformin cannot be held — close monitoring of renal function after the procedure is essential
Who is at highest risk for contrast nephropathy: Patients with pre-existing chronic kidney disease, diabetes, dehydration, heart failure, older age, or taking nephrotoxic drugs (NSAIDs, aminoglycosides).
💊 "Hold metformin before the scan." A patient with Type 2 diabetes is scheduled for a CT with contrast tomorrow. Metformin should have been held today — or at minimum, the ordering provider notified. This instruction is often missed in the flurry of pre-procedure orders. The nurse who catches it prevents a serious complication.
Surgery — Hold the Morning of
Perioperative fasting + anesthesia stresses the kidneys
Surgery requires the patient to be NPO — nothing by mouth. The fasting state, combined with the physiological stress of anesthesia and surgery, can lead to dehydration and reduced renal perfusion. In this setting, metformin clearance is impaired, and the risk of lactic acidosis increases.
Standard practice: Hold metformin the morning of surgery. It is typically not given with the restricted morning medications. Restart when the patient is eating and drinking normally and renal function is confirmed adequate post-operatively.
The blood glucose management gap: When metformin is held, blood sugar may rise. Patients and nurses need to know this is expected — and blood glucose should be monitored more frequently during the perioperative period, with insulin used for correction as needed.
💊 "NPO + metformin = hold it." A patient scheduled for surgery should not receive their morning metformin dose. It is one of the medications typically listed as "hold day of procedure" in pre-op instructions — but the nurse is the last safety check to ensure it was actually withheld.
Renal Failure — Contraindicated
Metformin is renally excreted — kidney failure means it accumulates
Metformin is excreted unchanged by the kidneys. When kidney function declines, metformin builds up in the blood — increasing the risk of lactic acidosis even without a precipitating event like contrast dye.
The eGFR thresholds (estimated glomerular filtration rate):
• eGFR above 45 mL/min: metformin generally safe, continue with monitoring
• eGFR 30–45 mL/min: use with caution, lower doses, monitor renal function every 3–6 months
• eGFR below 30 mL/min: metformin CONTRAINDICATED — risk of lactic acidosis too high
Nursing implication: When a patient on metformin has lab results showing worsening renal function — rising creatinine, falling eGFR — notify the provider before the next dose. The provider may need to hold or discontinue metformin.
💊 An elderly diabetic patient on metformin is admitted with a UTI. Her creatinine on admission is 2.8 (normal for her age is around 0.7–1.0) — her eGFR calculates to 22. Metformin is contraindicated at this level. Hold the dose, notify the provider. Her kidneys cannot clear it safely.
Lactic Acidosis
Recognizing the complication metformin is held to prevent
Signs and Symptoms of Lactic Acidosis
Nonspecific early, life-threatening late
Lactic acidosis is dangerous partly because its early signs are vague — patients and nurses may attribute them to other causes until the condition becomes severe.
Early signs:
• Nausea, vomiting, abdominal pain — similar to metformin's common GI side effects
• Malaise, weakness, fatigue
• Muscle pain
Late signs (severe lactic acidosis):
• Rapid, deep breathing (Kussmaul respirations) — the body trying to blow off acid as CO2
• Hypotension
• Hypothermia
• Altered mental status, stupor, coma
• Cardiac arrhythmias
Labs: Blood lactate above 5 mmol/L with blood pH below 7.35. Anion gap metabolic acidosis on ABG.
Treatment: Discontinue metformin. IV fluids. Bicarbonate for severe acidosis. Dialysis in severe cases to clear metformin. ICU level care.
💊 Lactic acidosis from metformin has a mortality rate of 30–50% when severe. Prevention — holding metformin before contrast and in renal failure — is infinitely better than treatment. This is a case where nursing vigilance about a pre-procedure medication order prevents a life-threatening event.
🏥 Clinical Scenario — Catching the Metformin-Contrast Interaction
Mr. Obi, 64 years old, Type 2 diabetes on metformin 1000mg twice daily, is admitted to your unit on Monday evening. He is scheduled for a cardiac catheterization with contrast on Tuesday morning at 8am. It is now 9pm Monday.
Review
Medication reconciliation on admission: You note metformin 1000mg BID on his home medication list. The cardiology admission orders include his home medications — metformin is listed to continue. Red flag — contrast procedure tomorrow morning. Metformin should be held.
Call
Notify cardiologist: "Dr. Adeyemi, Mr. Obi is scheduled for cath in the morning and his admission orders continue metformin. Should this be held given the contrast procedure?" Provider: "Good catch — hold metformin now and do not restart until we confirm renal function is normal 48 hours post-procedure." Order updated.
Labs
Renal function review: Pre-procedure creatinine 1.1 (normal), eGFR 68 — adequate for metformin under normal circumstances, but contrast exposure changes the calculation. Baseline documented for post-procedure comparison.
Post-cath
48 hours after procedure: Creatinine 1.3 — slight rise, consistent with mild contrast effect. eGFR 57. Provider reviews — not yet back to baseline. Metformin held another 24 hours. Day 3 post-procedure: creatinine 1.1, eGFR 68 — baseline restored. Metformin restarted. Patient educated on why it was held.
📌 NCLEX Application
Metformin questions on NCLEX focus on the contrast dye and renal failure interactions:
Pre-procedure: "A patient taking metformin is scheduled for a CT scan with contrast. Which action does the nurse take?" → Hold the metformin and notify the provider — metformin must be held before contrast to prevent lactic acidosis from contrast-induced nephropathy.
Renal failure: "A patient on metformin has a creatinine of 3.2 and eGFR of 18. What is the nurse's priority?" → Hold metformin and notify the provider — metformin is contraindicated when eGFR is below 30 due to lactic acidosis risk.
Hypoglycemia distinction: "A patient on metformin alone reports feeling shaky and anxious. Blood glucose is 74. What does the nurse assess for first?" → Metformin alone does not cause hypoglycemia (it only reduces liver glucose production, not below normal). A BG of 74 may simply be normal for this patient. However, assess for symptoms and recheck — if symptomatic, treat. If this patient is also on a sulfonylurea or insulin, hypoglycemia is more likely.
Mechanism: "Which statement best describes how metformin lowers blood glucose?" → It suppresses hepatic glucose production and improves insulin sensitivity — it does NOT stimulate insulin secretion (that is sulfonylureas) and does NOT cause hypoglycemia on its own.
⚠️ The Trap — Restarting Metformin Too Soon After Contrast
A patient had a cardiac catheterization with contrast yesterday. They are doing well, eating, and ready for discharge. The nurse reviews the discharge medication list — metformin is listed to restart "as previously prescribed."
The problem: Contrast-induced nephropathy typically peaks 24–48 hours after contrast administration. The renal damage is happening NOW — even though the patient looks fine. Restarting metformin while renal function is potentially compromised puts the patient at lactic acidosis risk.
The standard: Metformin should NOT be restarted until renal function is confirmed to be back at baseline — typically with a creatinine and eGFR check 48 hours after the procedure.
The nursing action: Before discharging a patient on metformin who has had contrast, verify that renal function labs have been checked post-procedure AND that the provider has specifically addressed metformin restart. "Continue home medications" is insufficient — metformin requires specific clearance based on post-contrast renal function.
NCLEX angle: "A patient who received IV contrast 24 hours ago is being discharged. Her discharge orders say to resume all home medications including metformin. What does the nurse do?" → Question the metformin restart order — renal function should be confirmed normal before restarting.
✓ Quick Self-Test
Answer before checking:
1. Why must metformin be held before contrast dye procedures?
2. What is the eGFR threshold below which metformin is contraindicated?
3. What life-threatening complication does metformin cause in renal failure?
4. Does metformin cause hypoglycemia? Why or why not?
5. When can metformin be safely restarted after a contrast procedure?
Answers:
1. Contrast dye can cause temporary kidney impairment (contrast nephropathy). Metformin is renally excreted — if kidneys cannot clear it, it accumulates and causes lactic acidosis by interfering with mitochondrial energy production.
2. eGFR below 30 mL/min — metformin is absolutely contraindicated. Use with caution between 30–45 mL/min.
3. Lactic acidosis — a potentially fatal condition where lactic acid builds up in the blood as cells switch to anaerobic metabolism. Mortality rate 30–50% in severe cases.
4. No — metformin does not cause hypoglycemia on its own. It works by reducing the liver's overproduction of glucose, not by driving glucose below normal levels. Hypoglycemia risk only increases when combined with insulin or sulfonylureas.
5. After confirming that renal function (creatinine and eGFR) has returned to baseline — typically 48 hours after the contrast procedure. Never restart based on how the patient feels — asymptomatic contrast nephropathy can still prevent safe metformin clearance.